AstraZeneca puts focus on drug law after units split up

WILMINGTON, DE: AstraZeneca has split its US public affairs from government relations with an eye toward putting more emphasis on managed care given the new Medicare prescription-drug law.

WILMINGTON, DE: AstraZeneca has split its US public affairs from government relations with an eye toward putting more emphasis on managed care given the new Medicare prescription-drug law.

"A clear way [the environment we operate in] has changed is the emergence of government as a key customer," said Rachel Bloom-Baglin, executive director, corporate communications.

Before the realignment, which took place earlier this month, public affairs oversaw government affairs, public policy, corporate external communications, brand communications, and corporate and community affairs.

Under the new structure, government affairs, public policy, and managed markets have their own group headed by Marion McCourt, now VP of government policy and managed markets. A new communications and external relations group encompasses the other areas, in addition to internal communications, formerly under human resources.

The public affairs group was headed by Alan Milbauer, who will retire in June. A successor for the new communications group has not yet been named.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Would you like to post a comment?

Please Sign in or register.